ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003